Zhou Li, Rui Jing-an, Ye Da-xiong, Wang Shao-bin, Chen Shu-guang, Qu Qiang
Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100032, China.
Chin Med Sci J. 2009 Dec;24(4):220-6. doi: 10.1016/s1001-9294(10)60005-3.
To validate the predictive power of the 5th and 6th editions of TNM staging system (TNM-5, TNM-6) in a Chinese patient cohort with hepatocellular carcinoma (HCC) sized > or = 5 cm after radical hepatectomy.
Consecutive 121 patients with HCC sized > or = 5 cm undergoing radical hepatectomy between January 1995 and December 2002 were included. The impact of clinicopathological variables on prognosis was determined by univariate and multivariate analyses, after excluding 2 perioperative deaths.
In univariate analysis, TNM-5 stage did not show prognostic significance for overall or disease-free survival, as opposed to TNM-6 stage, Edmondson-Steiner grade, portal vein tumor thrombosis (PVTT), vascular invasion, satellite nodule, Child-Pugh grade, and hepatitis B surface antigen (HBsAg) positivity. When these significant variables were entered in multivariate analysis, Edmondson-Steiner grade was the sole independent prognosticator for both overall and disease-free survival, whereas Child-Pugh grade independently influenced disease-free survival. However, TNM-6 stage lost its predictive potential in multivariate analysis.
Neither TNM-5 nor TNM-6 staging system is revealed to be independently prognostic in patients with HCC sized > or = 5 cm after radical hepatectomy. Therefore, TNM-6 calls for more support in many subsets of HCC patients.
验证第五版和第六版TNM分期系统(TNM-5、TNM-6)对根治性肝切除术后肿瘤大小≥5 cm的中国肝细胞癌(HCC)患者队列的预测能力。
纳入1995年1月至2002年12月期间连续121例行根治性肝切除且肿瘤大小≥5 cm的HCC患者。在排除2例围手术期死亡病例后,通过单因素和多因素分析确定临床病理变量对预后的影响。
单因素分析中,TNM-5分期对总生存期或无病生存期均无预后意义,而TNM-6分期、Edmondson-Steiner分级、门静脉癌栓(PVTT)、血管侵犯、卫星结节、Child-Pugh分级及乙肝表面抗原(HBsAg)阳性具有预后意义。多因素分析纳入这些显著变量后,Edmondson-Steiner分级是总生存期和无病生存期唯一的独立预后因素,而Child-Pugh分级独立影响无病生存期。然而,TNM-6分期在多因素分析中失去了预测潜力。
TNM-5和TNM-6分期系统对根治性肝切除术后肿瘤大小≥5 cm的HCC患者均无独立预后价值。因此,TNM-6分期在许多HCC患者亚组中需要更多支持。